A case series evaluation conducted by Professor Keith Harding, at the Welsh Wound Innovation Centre (WWIC) in Cardiff (UK), has investigated the therapeutic effect of geko™ neuromuscular electrostimulation device on wound healing outcomes over an 8-week period. Findings support use of the geko™ device in patients with painful venous and mixed leg ulceration in conjunction with best practice standard care. The geko™ device was effective in reducing the wound surface area and increasing the mean percentage of granulation tissue formation. 52% reported a substantial reduction in wound pain17.
Contrast speckle imaging from a single WWIC case study (shown opposite) demonstrates a 225% increase in microcirculatory blood flow in the wound bed, and a 67% increase in microcirculatory blood flow surrounding the peri-wound area, after activation of the geko™ device. The increase in blood flow to the wound bed promotes conditions favourable to wound healing17.
What is geko™ wound therapy?
Self-contained and wearable, the geko™ device:
Benefits of the geko™ device in wound patients
In addition, consider the geko™ device:
Unpublished evidence in an Ontario Home Care setting evaluation suggests this may be a first line treatment in conjunction with traditional therapy21.